a National Institute of Animal Biotechnology , Miyapur , India.
b Ella Foundation, Turkapally , Hyderabad , India.
Expert Opin Drug Discov. 2018 Feb;13(2):117-130. doi: 10.1080/17460441.2018.1413088. Epub 2017 Dec 11.
Vaccinology has evolved from a sub-discipline focussed on simplistic vaccine development based on antibody-mediated protection to a separate discipline involving epidemiology, host and pathogen biology, immunology, genomics, proteomics, structure biology, protein engineering, chemical biology, and delivery systems. Data mining in combination with bioinformatics has provided a scaffold linking all these disciplines to the design of vaccines and vaccine adjuvants. Areas covered: This review provides background knowledge on immunological aspects which have been exploited with informatics for the in silico analysis of immune responses and the design of vaccine antigens. Furthermore, the article presents various databases and bioinformatics tools, and discusses B and T cell epitope predictions, antigen design, adjuvant research and systems immunology, highlighting some important examples, and challenges for the future. Expert opinion: Informatics and data mining have not only reduced the time required for experimental immunology, but also contributed to the identification and design of novel vaccine candidates and the determination of biomarkers and pathways of vaccine response. However, more experimental data is required for benchmarking immunoinformatic tools. Nevertheless, developments in immunoinformatics and reverse vaccinology, which are nascent fields, are likely to hasten vaccine discovery, although the path to regulatory approval is likely to remain a necessary impediment.
疫苗学已经从一个专注于基于抗体介导保护的简单疫苗开发的子学科发展成为一个独立的学科,涉及流行病学、宿主和病原体生物学、免疫学、基因组学、蛋白质组学、结构生物学、蛋白质工程、化学生物学和输送系统。数据挖掘与生物信息学的结合为将所有这些学科联系起来设计疫苗和疫苗佐剂提供了一个支架。涵盖领域:本文提供了免疫学方面的背景知识,这些知识已通过信息学被利用来对免疫反应进行计算机分析和疫苗抗原的设计。此外,本文还介绍了各种数据库和生物信息学工具,并讨论了 B 细胞和 T 细胞表位预测、抗原设计、佐剂研究和系统免疫学,强调了一些重要的例子以及未来的挑战。专家意见:信息学和数据挖掘不仅减少了实验免疫学所需的时间,而且有助于鉴定和设计新型疫苗候选物,并确定疫苗反应的生物标志物和途径。然而,需要更多的实验数据来对免疫信息学工具进行基准测试。尽管如此,新兴领域的免疫信息学和反向疫苗学的发展很可能会加速疫苗的发现,尽管获得监管批准的途径仍可能是一个必要的障碍。